RAPT Therapeutics prices equity offering at $30 per share

* RAPT Therapeutics (NASDAQ:RAPT [https://seekingalpha.com/symbol/RAPT]) priced [https://seekingalpha.com/pr/20274668-rapt-therapeutics-announces-pricing-of-public-offering-of-common-stock] an underwritten public offering of ~8.33M shares at $30.00 per share.
* The underwriters have a 30-day option to purchase up to an additional 1.25M shares. All of the shares of common stock are being offered by RAPT.
* The gross proceeds from the offering to RAPT are expected to be ~$250M.
* The offering is expected to close on or about October 23, 2025.
* The stock price dropped 4% on Tuesday during after market hours of trading.

MORE ON RAPT THERAPEUTICS

* RAPT Therapeutics, Inc. (RAPT) Discusses Top Line Phase II Results for RPT-904 in Chronic Spontaneous Urticaria - Slideshow [https://seekingalpha.com/article/4831270-rapt-therapeutics-inc-rapt-discusses-top-line-phase-ii-results-for-rptminus-904-in-chronic]
* RAPT Therapeutics, Inc. (RAPT) Discusses Top Line Phase II Results for RPT-904 in Chronic Spontaneous Urticaria Transcript [https://seekingalpha.com/article/4831254-rapt-therapeutics-inc-rapt-discusses-top-line-phase-ii-results-for-rptminus-904-in-chronic]
* RAPT Therapeutics announces proposed public offering [https://seekingalpha.com/news/4506334-rapt-therapeutics-announces-proposed-public-offering]
* RAPT Therapeutics jumps on mid-stage data for urticaria candidate [https://seekingalpha.com/news/4505630-rapt-therapeutics-jumps-on-mid-stage-data-for-urticaria-candidate]
* Seeking Alpha’s Quant Rating on RAPT Therapeutics [https://seekingalpha.com/symbol/RAPT/ratings/quant-ratings]